Entry Detail



General Information

Database ID:exR0000052
RNA Name:ABCC4
RNA Type:mRNA
Chromosome:chr13
Starnd:-
Coordinate:
Start Site(bp):95019835End Site(bp):95301475
External Links:ENSG00000125257



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
KIF7
chr15
89608789
89655467
-
ERFE
chr2
238158970
238168900
+
POLR3D
chr8
22245133
22254601
+
SLC5A6
chr2
27199587
27212958
-
PIGC
chr1
172370189
172444086
-
AC007192.1
chr19
18153158
18178117
+
NDUFA10
chr2
239892450
240025345
-
ZBTB21
chr21
41986831
42010387
-
RUVBL1
chr3
128064778
128153914
-
ZDHHC20
chr13
21372573
21459370
-
IFI6
chr1
27666064
27672198
-
MYO1G
chr7
44962662
44979088
-
DPPA4
chr3
109326141
109337572
-
CCT8
chr21
29055805
29073797
-
BASP1
chr5
17065598
17276843
+
FNBP1
chr9
129887187
130043194
-
LTBP4
chr19
40592883
40629818
+
LARP1
chr5
154712843
154817605
+
RPL4
chr15
66498015
66524532
-
RRM1
chr11
4094707
4138932
+
SPOUT1
chr9
128819651
128829794
-
LLGL2
chr17
75525080
75575208
+
SACS
chr13
23328826
23433740
-
RPL27A
chr11
8682788
8714759
+
YIPF5
chr5
144158162
144170714
-
SRP14
chr15
40035690
40039181
-
FKBP8
chr19
18531751
18544077
-
KMT2B
chr19
35717973
35738878
+
DDX41
chr5
177511577
177516961
-
ING3
chr7
120950763
120977216
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
CRTC3-AS1
chr15
90620007
90717141
-
DLEU1
chr13
50082169
50906856
+
MALAT1
chr11
65497688
65506516
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.